Back to Search Start Over

Elucidating hematological profile and electrolyte balance in oral cancer patients.

Authors :
Sundaravadivelu I
Renu K
Kavitha S
Priya VV
Gayathri R
Ronsivalle V
Cicciù M
Minervini G
Source :
Minerva dental and oral science [Minerva Dent Oral Sci] 2024 Aug; Vol. 73 (4), pp. 224-229. Date of Electronic Publication: 2024 Jul 02.
Publication Year :
2024

Abstract

Background: Oral cancer is a serious health issue in both the developing and developed worlds, and it is one of the most common forms of cancer of the head and neck. In accordance with the 2017 World Health Organization classification, oral cancer can affect any part of the mouth, including the buccal mucosa, the front two-thirds of the tongue, the lip, the palate, the vestibule, the alveolus, the floor of the mouth, and the gingivae. Hematology and electrolyte balance have been proposed as tumor indicators and paths into cancer's genesis. Examining the patient's blood count and electrolyte levels in order to better understand their oral cancer.<br />Methods: Electrolyte abnormalities are common in cancer patients and may be caused by the disease itself or by treatment. Hyponatremia is the most frequent electrolyte problem in cancer patients, and it is typically caused by the syndrome of improper ADH secretion. Although electrolyte problems are associated with a worse prognosis for cancer patients, timely and effective therapy has the potential to enhance both short- and long-term results and quality of life. Hematological tests on patients with oral cancer, including differential cell count, white blood cell count, and hemoglobin level.<br />Results: Compared to healthy controls, oral cancer patients show statistically significant differences in a number of biochemical parameters, including electrolytes (sodium, P<0.05; potassium, P=0.89; chloride, P<0.05); differential count (neutrophils, P<0.05; basophils, P<0.05). A significant risk factor for cancer patients is an electrolyte imbalance, which has been linked to inappropriate anti-diabetic hormone release.<br />Conclusions: Clinicians will find these shifts in electrolytic level helpful in diagnosing and tracking oral cancer. Potentially malignant oral disorders and Oral squamous cell carcinoma may be better predicted using a combination of TLC, neutrophil, and lymphocyte counts, as shown in this study.

Details

Language :
English
ISSN :
2724-6337
Volume :
73
Issue :
4
Database :
MEDLINE
Journal :
Minerva dental and oral science
Publication Type :
Academic Journal
Accession number :
38953794
Full Text :
https://doi.org/10.23736/S2724-6329.24.04902-7